Skip to main content
Clover Health Investments Corp (CLOV)
Financial Services Financial
Stock AI

Clover Health Announces Participation in 2025 Citi Global Healthcare Conference

Last updated: November 17, 2025
Taurigo

Clover Health Investments Corp. (Nasdaq: CLOV) has officially announced that its Chief Financial Officer, Peter Kuipers, will be participating in the upcoming 2025 Citi Global Healthcare Conference. The event is scheduled for Thursday, December 4, 2025, at 11:15 a.m. Eastern Time. This appearance marks an important opportunity for the company to share its vision and strategies with a broader audience, particularly investors and industry stakeholders.

1. Live Webcast Access

For those interested in following the presentation, Clover Health will provide a live webcast of the event. Additionally, a replay of the presentation will be made available on Clover Health's investor relations website. This accessibility demonstrates Clover's commitment to transparency and engagement with its investors, ensuring that stakeholders can stay informed about the company’s developments and strategic direction.

2. About Clover Health

Clover Health is a physician enablement technology company that aims to enhance healthcare access for Medicare recipients. The company places a significant emphasis on serving seniors, a demographic that has historically faced challenges in accessing affordable, high-quality healthcare services. Clover Health's innovative approach is largely driven by its proprietary software platform, Clover Assistant, which aggregates patient data from various sources within the healthcare ecosystem. This technology supports clinical decision-making and aims to improve health outcomes by facilitating the early identification and management of chronic diseases.

Medicare Advantage Plans

Clover Health offers both PPO and HMO Medicare Advantage plans across several states, with a distinct focus on its flagship wide-network, high-choice PPO plans. This variety of options allows seniors to choose a plan that best suits their needs, reflecting Clover Health’s commitment to providing flexible and comprehensive care solutions.

Expanding Reach Through Counterpart Health

Beyond its Medicare Advantage offerings, Clover Health also extends its data-driven technology through its subsidiary, Counterpart Health. This initiative aims to enhance patient outcomes and reduce healthcare costs on a national scale, making Clover’s innovative solutions available to healthcare providers outside its own plan network.

3. Impact of Technology on Health Outcomes

The company has published data showcasing the effectiveness of its technology in various critical health areas, including Medication Adherence, Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and care for Underserved Populations. Clover Health's focus on early identification and management of conditions such as Diabetes and Chronic Kidney Disease highlights its commitment to proactive healthcare, potentially leading to better health outcomes for its members.

4. Conclusion

Clover Health's participation in the 2025 Citi Global Healthcare Conference is poised to underscore the company's ongoing commitment to enhancing healthcare access for seniors and improving overall health outcomes through innovative technology. As the date approaches, stakeholders and interested parties will undoubtedly be keen to hear insights from CFO Peter Kuipers regarding Clover Health's strategic initiatives and future growth prospects.

You may also be interested in:
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.